NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Cholesterol Guidelines and NLA Involvement
The National Lipid Association remains focused on enhancing the practice of lipid management in clinical medicine, with guideline education and participation as a critical part…
S2E2: CAC Scoring: A Discussion on the Recent NLA Scientific Statement
Dr. Alan Brown sits down with Dr. Carl Orringer and Dr. Michael Blaha to take a deeper look at the recent NLA scientific statement on…
The National Lipid Association scientific statement on coronary artery calcium (CAC) scoring to guide preventive strategies for ASCVD risk reduction
An Expert Panel of the National Lipid Association reviewed the evidence related to the use of coronary artery calcium (CAC) scoring in clinical practice for…
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
The 2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol reaffirmed that lifestyle changes and statin treatment are therapeutic cornerstones…
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
Lipoprotein(a) [Lp(a)] is a well-recognized, independent risk factor for atherosclerotic cardiovascular disease, with elevated levels estimated to be prevalent in 20% of the population.
Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit: A consensus statement from the National Lipid Association
Acquisition costs and cost-effectiveness have limited access and recommendations to use proprotein convertase subtilisin/kexin type 9 (PCSK9)–inhibiting monoclonal antibodies (mAbs).
NLA Recommendations for Patient-Centered Management of Dyslipidemia
The leadership of the National Lipid Association convened an Expert Panel to develop a consensus set of recommendations for patient-centered management of dyslipidemia in clinical…